Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Amant

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|June 1, 2005
The rationale for comprehensive surgical staging in endometrial carcinosarcomaFrederic Amant
Women'S Health (London, England)|October 7, 2009
Different subtypes of uterine sarcoma require a separate therapeutic approachFrederic Amant
American Journal of Obstetrics and Gynecology|July 13, 2002
PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomasFrederic Amant, Ignace Vergote
Gynecologic Oncology|March 30, 2004
Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcomaFrederic Amant, Ignace Vergote
Gynecologic Oncology|September 19, 2006
Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancerIgnace Vergote, Frederic Amant
The Lancet. Oncology|July 20, 2010
Laparoscopic hysterectomy for early endometrial cancerIgnace Vergote, Frederic Amant, Patrick Neven
International Journal of Surgical Pathology|April 22, 2016
Mesonephric (Wolffian) Pseudoendometrioid Carcinoma of the Broad Ligament, Arising From a Papillary CystadenomaPhilippe Moerman, Frederic Amant, Ignace Vergote
Gynecologic Oncology|September 14, 2010
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?Ignace Vergote, Frederic Amant, Karin Leunen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Is it safe to treat endometrial carcinoma endoscopically?Ignace Vergote, Frederic Amant, Patrick Neven
Gynecologic Oncology|October 20, 2004
The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandonedFrederic Amant, I Vergote, Ph Moerman
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|June 1, 2005
The rationale for comprehensive surgical staging in endometrial carcinosarcomaFrederic Amant
Women'S Health (London, England)|October 7, 2009
Different subtypes of uterine sarcoma require a separate therapeutic approachFrederic Amant
American Journal of Obstetrics and Gynecology|July 13, 2002
PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomasFrederic Amant, Ignace Vergote
Gynecologic Oncology|March 30, 2004
Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcomaFrederic Amant, Ignace Vergote
Gynecologic Oncology|September 19, 2006
Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancerIgnace Vergote, Frederic Amant
The Lancet. Oncology|July 20, 2010
Laparoscopic hysterectomy for early endometrial cancerIgnace Vergote, Frederic Amant, Patrick Neven
International Journal of Surgical Pathology|April 22, 2016
Mesonephric (Wolffian) Pseudoendometrioid Carcinoma of the Broad Ligament, Arising From a Papillary CystadenomaPhilippe Moerman, Frederic Amant, Ignace Vergote
Gynecologic Oncology|September 14, 2010
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?Ignace Vergote, Frederic Amant, Karin Leunen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Is it safe to treat endometrial carcinoma endoscopically?Ignace Vergote, Frederic Amant, Patrick Neven
Gynecologic Oncology|October 20, 2004
The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandonedFrederic Amant, I Vergote, Ph Moerman
Pageof 18